)
Pharmanutra (PHN) investor relations material
Pharmanutra Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate structure and global presence
Operates globally with subsidiaries in the USA and Spain, and acquired Akern for R&D in bioimpedance devices.
Presence in 81 countries through 53 international partners.
Expanded product distribution in China via cross-border e-commerce and digital platforms.
Product portfolio and innovation
Main product families include SiderAL, Apportal, Cetilar, UltraMag, and Sidevit, covering nutraceuticals and medical devices.
Four new products launched in September 2026, including Sucrosomial Creatine; three more and a new line planned for 2027.
Sucrosomial technology applied to iron, vitamins, and minerals, offering higher absorption and effectiveness.
Financial performance and market growth
Domestic H1 2026 revenues grew 9.3%, with increasing contributions from Akern and Cetilar Nutrition.
Sell-out volumes up 11% year-on-year across all channels in H1 2026.
Outperformed the Italian market in all product categories, with strong growth in SiderAL, Cetilar, and Apportal lines.
- Net revenues up 17.9% to €73M, driven by international and new business unit growth.PHN
H1 2026 - H1 2024 delivered 13% sales growth, 23% higher net result, and robust international expansion.PHN
H1 2024 - Q1 2026 saw 24.5% revenue growth and 41.9% profit rise, driven by global and segment expansion.PHN
Q1 2026 - Revenue and profit surged on robust global sales and new launches, with further growth expected.PHN
Q3 2024 - Strong revenue and EBITDA growth, robust cash flow, and expanding international presence.PHN
H2 2024 - Net revenues up 11.2% to €26.4M, with stable EBITDA and strong international growth.PHN
Q1 2025 - H1 2025 revenues grew 10.4% to €61.9M, with net profit up 3.2% to €9.2M and margins slightly down.PHN
H1 2025 - Revenue up 13.3% to €94.6M, net profit up 6.4%, driven by international and product growth.PHN
Q3 2025 - Revenue up 14% YoY, net result €20M, strong cash generation, and robust 2026 growth outlook.PHN
H2 2025
Next Pharmanutra earnings date
Next Pharmanutra earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage
)